Use of gabapentin during pregnancy to reduce brain damage in new-born infants that are premature or at risk of perinatal asphyxia.
Halabe Bucay
Alberto
A
D000588:Amines / Q000627:therapeutic use*; D001238:Asphyxia Neonatorum / Q000150:complications* / Q000188:drug therapy*; D001925:Brain Damage, Chronic / Q000188:drug therapy* / Q000209:etiology; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D005260:Female; D000077206:Gabapentin; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D008954:Models, Biological; D011247:Pregnancy; D012307:Risk Factors; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use*
D000588:Amines; D002121:Calcium Channel Blockers; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin